SPARC and malignant colon neoplasm: As for the relationship of SPARC and 5-FU, our preliminary results demonstrated that down regulation of SPARC in GC might enhance 5-FU sensitivity, which is distinct with the previous reports about SPARC in liver and colon cancers [35, 36], and the diversity is supposed to be related with the cancer type difference.